Analyst Ratings
Upgrades, downgrades, and price-target changes from Wall Street firms.
HC Wainwright Reiterates Buy Rating for Ocular Therapeutix
HC Wainwright maintains its buy rating for Ocular Therapeutix with a $25 price target.
Leerink Partners Reiterates Buy Rating on uniQure N.V.
Leerink Partners maintains its buy rating on uniQure N.V. with a $70 price target.
B. Riley Securities Reiterates Buy Rating for MSIF
B. Riley Securities maintains its buy rating on MSIF with a $13 price target.
RBC Capital Reiterates Buy Rating on uniQure N.V.
RBC Capital maintains its buy rating on uniQure N.V. with a $65 price target.
Scotiabank Reiterates Buy Rating on Essex Property Trust
Scotiabank maintains its buy rating for Essex Property Trust with a target price of $290.
Wedbush Reiterates Buy Rating on Micron Technology, Inc.
Wedbush maintains its buy rating on Micron Technology with a $1,300 price target.
Stifel Reiterates Buy Rating on Jabil Inc. (JBL)
Stifel has reiterated its buy rating for Jabil Inc., setting a price target of $460.
TD Cowen Reiterates Buy Rating for BrightSpring Health Services
TD Cowen maintains its buy rating on BrightSpring Health Services with a price target of $81.
Stifel Reiterates Buy Rating on Micron Technology, Target Set at $1,500
Stifel maintains a bullish outlook on Micron Technology with a $1,500 price target.
Scotiabank Reaffirms Buy Rating for Janus Living, Inc.
Scotiabank maintains its buy rating on Janus Living with a $29 price target.
TD Cowen Reiterates Buy Rating on Elanco Animal Health
TD Cowen maintains its optimistic outlook on Elanco Animal Health with a $32 price target.
Scotiabank Reiterates Sell Rating on Mid-America Apartment Communities
On June 18, 2026, Scotiabank maintained its sell rating for MAA with a $129 price target.
TD Cowen Reiterates Buy Rating for JFrog Ltd. (FROG)
TD Cowen maintains its buy rating on JFrog Ltd. with a $100 price target.
TD Cowen Reiterates Buy Rating on Krystal Biotech
TD Cowen reaffirms its buy rating on Krystal Biotech with a $403 price target.
Scotiabank Reiterates Buy Rating on The Macerich Company
Scotiabank maintains its buy rating for The Macerich Company, setting a $27 price target.
Stifel Reiterates Buy Rating on Pebblebrook Hotel Trust
Analyst Simon Yarmak of Stifel maintains a buy rating with a $20.25 target for Pebblebrook Hotel Trust.
Needham Reiterates Buy Rating for TTM Technologies, Inc.
Needham has reiterated its buy rating on TTM Technologies, Inc. with a price target of $220.
Stifel Reiterates Buy Rating on SLB N.V.
Stifel maintains its buy rating for SLB N.V., setting a price target of $64.
Scotiabank Reaffirms Buy Rating on Public Storage
Scotiabank maintains its buy rating for Public Storage, setting a price target of $342.
Scotiabank Reiterates Buy Rating on Postal Realty Trust
Scotiabank maintains its buy rating on Postal Realty Trust, setting a price target of $25.
Susquehanna Reiterates Buy Rating on Sphere Entertainment Co.
Susquehanna maintains its buy rating for SPHR, setting a $182 price target.
Baird Reiterates Buy Rating on Nurix Therapeutics, Inc.
Baird maintains its Buy rating with a $33 price target for Nurix Therapeutics.
Wells Fargo Reiterates Buy Rating on Citigroup Inc.
Wells Fargo maintains its buy stance on Citigroup with a $165 target.
Wells Fargo Reiterates Buy Rating on Equifax with $220 Target
Wells Fargo maintains its buy rating on Equifax, setting a price target of $220.
